185 related articles for article (PubMed ID: 22998042)
1. Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry.
Hiemke C; Shams M
Curr Drug Deliv; 2013 Feb; 10(1):46-53. PubMed ID: 22998042
[TBL] [Abstract][Full Text] [Related]
2. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 22053351
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.
Hiemke C
Eur J Clin Pharmacol; 2008 Feb; 64(2):159-66. PubMed ID: 18196227
[TBL] [Abstract][Full Text] [Related]
4. The need to improve current psychopharmacotherapy before developing new drugs.
Ceskova E
Expert Opin Pharmacother; 2014 Oct; 15(14):1969-73. PubMed ID: 25146687
[TBL] [Abstract][Full Text] [Related]
5. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.
Baumann P; Hiemke C; Ulrich S; Eckermann G; Gaertner I; Gerlach M; Kuss HJ; Laux G; Müller-Oerlinghausen B; Rao ML; Riederer P; Zernig G;
Pharmacopsychiatry; 2004 Nov; 37(6):243-65. PubMed ID: 15551191
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring in neuropsychopharmacology: does it hold its promises?
Hiemke C
Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():21-7. PubMed ID: 18344046
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic monitoring of psychoactive drugs - antidepressants: a review.
Grundmann M; Kacirova I; Urinovska R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Mar; 159(1):35-43. PubMed ID: 23549513
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of CYP genotyping in psychiatry.
Spina E; de Leon J
J Neural Transm (Vienna); 2015 Jan; 122(1):5-28. PubMed ID: 25200585
[TBL] [Abstract][Full Text] [Related]
9. AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011.
Hiemke C; Baumann P; Bergemann N; Conca A; Dietmaier O; Egberts K; Fric M; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Jaquenoud Sirot E; Kirchherr H; Laux G; Lutz UC; Messer T; Müller MJ; Pfuhlmann B; Rambeck B; Riederer P; Schoppek B; Stingl J; Uhr M; Ulrich S; Waschgler R; Zernig G
Pharmacopsychiatry; 2011 Sep; 44(6):195-235. PubMed ID: 21969060
[TBL] [Abstract][Full Text] [Related]
10. Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.
van der Weide J; van Baalen-Benedek EH; Kootstra-Ros JE
Ther Drug Monit; 2005 Aug; 27(4):478-83. PubMed ID: 16044105
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring and pharmacogenetics--is this a way towards creative psychopharmacotherapy?
Plesničar BK; Plesničar A
Psychiatr Danub; 2014 Jun; 26(2):96-9. PubMed ID: 24909244
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic drug monitoring in child and adolescent psychiatry--practical recommendations].
Gerlach M; Rothenhöfer S; Mehler-Wex C; Fegert JM; Schulz E; Wewetzer C; Warnke A
Z Kinder Jugendpsychiatr Psychother; 2006 Jan; 34(1):5-13. PubMed ID: 16485609
[TBL] [Abstract][Full Text] [Related]
13. Outliers on the dose-response curve: how to minimize this problem using therapeutic drug monitoring, an underutilized tool in psychiatry.
Preskorn SH
J Psychiatr Pract; 2010 May; 16(3):177-82. PubMed ID: 20485106
[TBL] [Abstract][Full Text] [Related]
14. Psychotropic medications and cytochrome P450 2D6: pharmacokinetic considerations in the elderly.
Shulman RW; Ozdemir V
Can J Psychiatry; 1997 Jun; 42 Suppl 1():4S-9S. PubMed ID: 9220124
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring of psychotropic drugs. TDM "nouveau".
Bengtsson F
Ther Drug Monit; 2004 Apr; 26(2):145-51. PubMed ID: 15228155
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].
Unterecker S; Hefner G; Baumann P; Gründer G; Bergemann N; Clement HW; Conca A; Deckert J; Domschke K; Eckermann G; Egberts K; Gerlach M; Greiner C; Haen E; Havemann-Reinecke U; Helmer R; Janssen G; Jaquenoud E; Laux G; Messer T; Mössner R; Müller MJ; Paulzen M; Pfuhlmann B; Riederer P; Saria A; Schoppek B; Schoretsanitis G; Schwarz M; Gracia MS; Stegmann B; Steimer W; Stingl JC; Uhr M; Ulrich S; Waschgler R; Zernig G; Zurek G; Hiemke C
Nervenarzt; 2019 May; 90(5):463-471. PubMed ID: 30446893
[TBL] [Abstract][Full Text] [Related]
17. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
Hiemke C; Bergemann N; Clement HW; Conca A; Deckert J; Domschke K; Eckermann G; Egberts K; Gerlach M; Greiner C; Gründer G; Haen E; Havemann-Reinecke U; Hefner G; Helmer R; Janssen G; Jaquenoud E; Laux G; Messer T; Mössner R; Müller MJ; Paulzen M; Pfuhlmann B; Riederer P; Saria A; Schoppek B; Schoretsanitis G; Schwarz M; Gracia MS; Stegmann B; Steimer W; Stingl JC; Uhr M; Ulrich S; Unterecker S; Waschgler R; Zernig G; Zurek G; Baumann P
Pharmacopsychiatry; 2018 Jan; 51(1-02):9-62. PubMed ID: 28910830
[TBL] [Abstract][Full Text] [Related]
18. Personalized medicine in psychiatry: new technologies and approaches.
Costa e Silva JA
Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.
Eilers R
Clin Pharmacokinet; 1995 Dec; 29(6):442-50. PubMed ID: 8787949
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of pharmacogenetics in psychiatry].
Skrętkowicz J; Barańska M; Rychlik-Sych M
Wiad Lek; 2013; 66(2 Pt 2):185-91. PubMed ID: 25775815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
